Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A24610 | 22692588 | Int J Mol Med | Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis. | 2012 | Details |
A24612 | 22691891 | Minerva Endocrinol | Is NAFLD an independent risk factor for increased IMT in T2DM? | 2012 | Details |
A24613 | 22691278 | BMC Gastroenterol | A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease. | 2012 | Details |
A24619 | 22684858 | Hepatology | Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. | 2012 | Details |
A24620 | 22684314 | Acta Diabetol | Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society. | 2012 | Details |
A24626 | 22676641 | Clin Endocrinol (Oxf) | Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease. | 2013 | Details |
A24627 | 22676459 | Cardiovasc Diabetol | Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering? | 2012 | Details |
A24629 | 22673924 | Int J Vitam Nutr Res | Therapeutic effect of metformin and vitamin E versus prescriptive diet in obese adolescents with fatty liver. | 2011 | Details |
A24630 | 22673296 | Endocr J | A case of glycogenic hepatopathy developed in a patient with new-onset fulminant type 1 diabetes: the role of image modalities in diagnosing hepatic glycogen deposition including gradient-dual-echo MRI. | 2012 | Details |
A24633 | 22672485 | J Am Acad Nurse Pract | Nonalcoholic fatty liver disease: the hepatic metabolic syndrome. | 2012 | Details |
A24634 | 22672330 | Diabet Med | Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. | 2012 | Details |
A24636 | 22668875 | Eur J Gastroenterol Hepatol | Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used. | 2012 | Details |
A24637 | 22668639 | J Hepatol | Critical role of cytochrome P450 2E1 (CYP2E1) in the development of high fat-induced non-alcoholic steatohepatitis. | 2012 | Details |
A24640 | 22661277 | Endocrine | Assessment of endothelial function in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24641 | 22659415 | Biochem Biophys Res Commun | GH-independent IGF-I action is essential to prevent the development of nonalcoholic steatohepatitis in a GH-deficient rat model. | 2012 | Details |
A24653 | 22646469 | Platelets | Mean platelet volume in biopsy-proven non-alcoholic fatty liver disease. | 2012 | Details |
A24655 | 25755424 | J Clin Exp Hepatol | Management of Non-alcoholic Fatty Liver Disease and Steatohepatitis. | 2012 | Details |
A24658 | 25755421 | J Clin Exp Hepatol | Non-alcoholic Fatty Liver Disease: East Versus West. | 2012 | Details |
A24666 | 22634121 | J Hepatol | D-livering the message: the importance of vitamin D status in chronic liver disease. | 2012 | Details |
A24667 | 22633783 | J Pediatr | The effect of cysteamine bitartrate on adiponectin multimerization in non-alcoholic fatty liver disease and healthy subjects. | 2012 | Details |
A24669 | 22628617 | J Lipid Res | Tsc2, a positional candidate gene underlying a quantitative trait locus for hepatic steatosis. | 2012 | Details |
A24673 | 22619360 | Endocrinology | Endoplasmic reticulum stress induces the expression of fetuin-A to develop insulin resistance. | 2012 | Details |
A24674 | 22617751 | Curr Opin Lipidol | Nonalcoholic fatty liver disease and lipids. | 2012 | Details |
A24675 | 22617564 | Curr Opin Clin Nutr Metab Care | Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease. | 2012 | Details |
A24676 | 22617561 | Curr Opin Clin Nutr Metab Care | DNA methylation and hepatic insulin resistance and steatosis. | 2012 | Details |
A24677 | 22616493 | Acta Gastroenterol Latinoam | IGF-1 levels in different stages of liver steatosis and its association with metabolic syndrome. | 2012 | Details |
A24685 | 22610995 | Obes Surg | Impact of weight-loss surgery and diabetes status on serum ALT levels. | 2012 | Details |
A24686 | 22610002 | Clin Gastroenterol Hepatol | Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24688 | 22609053 | Trends Endocrinol Metab | Role of ceramides in nonalcoholic fatty liver disease. | 2012 | Details |
A24690 | 22596186 | Curr Opin Cardiol | Nonalcoholic fatty liver disease and vascular risk. | 2012 | Details |
A24703 | 22582214 | J Appl Physiol (1985) | Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease. | 2012 | Details |
A24704 | 22579612 | Mol Cell Endocrinol | The role of angiotensin II in nonalcoholic steatohepatitis. | 2012 | Details |
A24705 | 22577564 | Int J Hepatol | Role of NKT Cells in the Pathogenesis of NAFLD. | 2012 | Details |
A24707 | 22576780 | Diabetes Metab Res Rev | Diabetic fatty liver disease is associated with specific changes in blood-borne markers. | 2012 | Details |
A24708 | 22576368 | Mol Med | Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice. | 2012 | Details |
A24712 | 22570745 | Gut Liver | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. | 2012 | Details |
A24713 | 22570680 | Therap Adv Gastroenterol | Secondary causes of nonalcoholic fatty liver disease. | 2012 | Details |
A24714 | 22569763 | J Gastroenterol | Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease. | 2012 | Details |
A24718 | 22567185 | World J Hepatol | G6PT-H6PDH-11βHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome. | 2012 | Details |
A24719 | 22565095 | Nat Rev Gastroenterol Hepatol | Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. | 2012 | Details |
A24722 | 22561686 | Nat Med | Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. | 2012 | Details |
A24724 | 22560210 | Cell Metab | Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. | 2012 | Details |
A24732 | 22551412 | J Med Food | Raspberry ketone protects rats fed high-fat diets against nonalcoholic steatohepatitis. | 2012 | Details |
A24735 | 22546916 | Comp Med | Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in Guinea pigs. | 2012 | Details |
A24736 | 22546860 | J Clin Invest | The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. | 2012 | Details |
A24737 | 22546752 | Eur J Gastroenterol Hepatol | γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. | 2012 | Details |
A24742 | 22545359 | Pak J Biol Sci | Non alcoholic fatty liver disease, insulin resistance, dyslipidemia and atherogenic ratios in epileptic children and adolescents on long term antiepileptic drug therapy. | 2012 | Details |
A24743 | 22544914 | J Clin Endocrinol Metab | Children with NAFLD are more sensitive to the adverse metabolic effects of fructose beverages than children without NAFLD. | 2012 | Details |
A24745 | 22543623 | Eur J Nutr | A moderate weight reduction through dietary intervention decreases hepatic fat content in patients with non-alcoholic fatty liver disease (NAFLD): a pilot study. | 2012 | Details |
A24747 | 22541252 | Gastroenterol Hepatol | [Influence of non-alcoholic fatty liver disease on cardiovascular disease]. | 2012 | Details |
A24749 | 22539458 | Diabetes Metab Res Rev | Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance. | 2012 | Details |
A24752 | 22536512 | Int J Hepatol | Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic Fatty liver disease. | 2012 | Details |
A24757 | 22532269 | Hepatology | Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: a pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study. | 2012 | Details |
A24758 | 22531980 | Hepatology | Retinoids ameliorate insulin resistance in a leptin-dependent manner in mice. | 2012 | Details |
A24760 | 22530350 | Eur Rev Med Pharmacol Sci | Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease. | 2012 | Details |
A24764 | 22525431 | Lab Invest | Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function. | 2012 | Details |
A24766 | 22521558 | Clin Res Hepatol Gastroenterol | Non-alcoholic fatty liver disease in children. | 2012 | Details |
A24770 | 22520641 | Liver Int | Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. | 2012 | Details |
A24772 | 22519397 | Curr Med Chem | Mechanisms involved in the protective effects of metformin against nonalcoholic fatty liver disease. | 2012 | Details |
A24774 | 22509248 | PLoS One | Sinusoidal endothelial dysfunction precedes inflammation and fibrosis in a model of NAFLD. | 2012 | Details |
A24780 | 22505276 | Hepatology | Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism. | 2012 | Details |
A24781 | 22505194 | Hepatology | Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. | 2012 | Details |
A24784 | 22500386 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Clinical study of Qinggan Huatan Huoxue Recipe on the treatment of non-alcoholic steatohepatitis]. | 2012 | Details |
A24785 | 22498245 | Best Pract Res Clin Endocrinol Metab | Metabolic insights from extreme human insulin resistance phenotypes. | 2012 | Details |
A24786 | 22496902 | PLoS One | Effect of dietary advanced glycation end products on mouse liver. | 2012 | Details |
A24787 | 22495402 | Eur J Gastroenterol Hepatol | Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24798 | 22481454 | Ann Hepatol | High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity. | 2012 | Details |
A24802 | 22476041 | J Clin Gastroenterol | Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease. | 2012 | Details |
A24803 | 22475139 | Zhonghua Gan Zang Bing Za Zhi | [Expression and significance of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in hepatocyte steatosis model]. | 2012 | Details |
A24804 | 22474039 | Diabetes Care | Multiorgan insulin sensitivity in lean and obese subjects. | 2012 | Details |
A24813 | 22468076 | World J Gastroenterol | Genetically modified mouse models for the study of nonalcoholic fatty liver disease. | 2012 | Details |
A24814 | 22468051 | Indian J Clin Biochem | Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease. | 2011 | Details |
A24817 | 22467327 | J Clin Lab Anal | Visfatin levels in nonalcoholic fatty liver disease. | 2012 | Details |
A24818 | 22467277 | Hepatology | Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. | 2012 | Details |
A24823 | 22464705 | Zhonghua Gan Zang Bing Za Zhi | [The effect of resistin on nuclear factor-kB and tumor necrosis factor-a expression in hepatic steatosis]. | 2012 | Details |
A24824 | 22464551 | Nutrition | Non-alcoholic fatty liver disease in children now: lifestyle changes and pharmacologic treatments. | 2012 | Details |
A24827 | 22458550 | Nutr Metab (Lond) | Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL/6 J mice fed a high-fat diet via fatty acid oxidation. | 2012 | Details |
A24829 | 22457136 | Chin J Integr Med | Ping-tang Recipe () improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats. | 2012 | Details |
A24832 | 22450341 | Hormones (Athens) | Adiponectin: regulation of its production and its role in human diseases. | 2012 | Details |
A24833 | 22449814 | Curr Opin Lipidol | Connecting mTORC1 signaling to SREBP-1 activation. | 2012 | Details |
A24836 | 22444524 | Dig Liver Dis | Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome. | 2012 | Details |
A24837 | 22442265 | J Clin Endocrinol Metab | Intrahepatic insulin exposure, intrahepatocellular lipid and regional body fat in nonalcoholic fatty liver disease. | 2012 | Details |
A24838 | 22441997 | Zentralbl Chir | [NASH (non-alcoholic steatohepatitis): fatty liver or fatal liver disease?]. | 2012 | Details |
A24840 | 22438225 | J Clin Endocrinol Metab | Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. | 2012 | Details |
A24841 | 22438219 | Obes Surg | Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up. | 2012 | Details |
A24842 | 22436747 | Nat Rev Mol Cell Biol | MicroRNAs in metabolism and metabolic disorders. | 2012 | Details |
A24845 | 22434759 | Pediatr Obes | Energy expenditure and insulin sensitivity evaluation in obese children affected by hepatosteatosis. | 2012 | Details |
A24847 | 22434756 | Pediatr Obes | Influence of elevated liver fat on circulating adipocytokines and insulin resistance in obese Hispanic adolescents. | 2012 | Details |
A24864 | 22420611 | Clin Sci (Lond) | Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet. | 2012 | Details |
A24871 | 22418886 | Semin Liver Dis | Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. | 2012 | Details |
A24873 | 22418884 | Semin Liver Dis | NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression? | 2012 | Details |
A24879 | 22408036 | Eur Heart J | Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? | 2012 | Details |
A24880 | 22407492 | Endocrine | Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women. | 2012 | Details |
A24883 | 22397032 | Adv Clin Chem | Fetuin-A and the cardiovascular system. | 2012 | Details |
A24886 | 22395062 | J Clin Gastroenterol | Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease. | 2012 | Details |
A24887 | 22394502 | J Lipid Res | Evidence for regulated monoacylglycerol acyltransferase expression and activity in human liver. | 2012 | Details |
A24888 | 22394108 | Metab Syndr Relat Disord | Nonalcoholic fatty liver disease: a nutritional approach. | 2012 | Details |
A24889 | 22391060 | Proc Nutr Soc | Potential health benefits of moderate alcohol consumption: current perspectives in research. | 2012 | Details |
A24892 | 22386931 | Metabolism | Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men. | 2012 | Details |
A24894 | 22385956 | Cell | Mechanisms for insulin resistance: common threads and missing links. | 2012 | Details |